What is Invokana Used for?

Invokana What is it for? It has many spellings used to search Google such as, invokana, invocona, inokana, invokanna, invocanna, invakana, invikana, innvokana, envocana, inkovana, invoka, imvokana, invocana, ivocana. Regardless how you spell it, it’s the same drug.

So, what is Invokana for? why is it prescribed, when is it prescribed, and who should not take it?  These are all very important questions to answer before considering taking Invokana. Invokana is a type 2 diabetes drug also known Canagliflozin. It was developed by Mitsubishi Tanabe Pharma and is marketed under a license by Janssen, a division of Johnson & Johnson. Type 2 diabetes is the most common form of the disease, affecting about 24 million people and accounting for more than 90 percent of diabetes cases diagnosed in the United States. Over time, high blood sugar levels can increase the risk for serious complications, including heart disease, blindness, and nerve and kidney damage.

How Does Invokana Work is It Safe – Does It Cause Weight Loss?

Invokana is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the renal glucose reabsorption (SGLT1 being responsible for the remaining 10%). Blocking this transporter causes up to 119 grams of blood glucose per day to be eliminated through the urine, corresponding to 476 kilocalories. Additional water is eliminated by osmotic diuresis, resulting in a lowering of blood pressure.

Why is Invokana prescribed? According to the FDA, its safety and effectiveness were evaluated in nine clinical trials involving over 10,285 patients with type 2 diabetes. The initial clinical trials showed improvement in hemoglobin A1c levels (a measure of blood sugar control) and fasting plasma glucose (blood sugar) levels.

Other SGLT2 inhibitors include:

  • Farxiga
  • Invokamet
  • Gylcambi
  • Jardiance
  • Xigduo XR

When Was Invokana Put on the Market?

Invokana became the first SGLT2 inhibitor to be approved in the United States. As a condition of approval, the FDA is requiring five postmarketing studies for Invokana: a cardiovascular outcomes trial; an enhanced pharmacovigilance program to monitor for malignancies, serious cases of pancreatitis, severe hypersensitivity reactions, photosensitivity reactions, liver abnormalities, and adverse pregnancy outcomes; a bone safety study; and two pediatric studies under the Pediatric Research Equity Act (PREA), including a pharmacokinetic and pharmacodynamic study and a safety and efficacy study.

What are the Minor Side Effects?

Why does invokana cause yeast infections? Common minor side effects of the drug are vaginal yeast infection, urinary tract infection, sudden dizziness and fainting.

Major Problems Discovered

1. Does Invokana cause ketoacidosis? The FDA issued a warning letter. On May 15, 2015, the FDA issued a Safety Communication warning consumers that SGLT2 inhibitors such as Invokana may result in a dangerous condition called ketoacidosis. Ketoacidosis is a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization.

The FDA searched the Adverse Event Reporting System (FAERS) database and identified 20 cases of acidosis reported as diabetic ketoacidosis (DKA), ketoacidosis, or ketosis in patients treated with SGLT2 inhibitors from March 2013 to June 6, 2014 in which the consumer was hospitalized. The FDA is going to follow the drug for further study.

2. Institute for Safe Medicine Practices. According to a report from the Institute for Safe Medication Practices (ISMP), Invokana has been linked to hundreds of severe adverse events. ISMP claims it counted over 450 adverse events for its first 12 months on the market, including:

  • Kidney failure or damage
  • Kidney stones
  • Fluid/electrolyte problems
  • Urinary tract infections

Janssen claims that its product already providing warnings about the possibility of kidney failure. The ISMP report questions whether the benefits of the drug outweigh the risks. (See  label) currently warns of the possibility for “impairment of renal function,” but does not address kidney failure specifically.

What to do if You Have Experienced Kidney Failure or Diabetic Ketoacidosis After Taking Invokana

As mentioned above, ISMP claims it counted over 450 adverse events for Invokana in its first 12 months on the market. A number of concerns and questions about it have been asked. If you have any of the following questions because you are concerned of personal adverse effects of Invokana contact us and we will let you know if you have a case. Questions include, does Invokana cause hyperkalemia, ketoacidosis, weight loss, or does Invokana cause yeast infections, or does it cause amputation.

Ashcraft & Gerel is still investigating whether they will pursue litigation against the makers of Invokana. If you believe you have been injured, however, please contact us. We may be able to assist you in the future or answer any questions you may have. Contact as at 703-931-5500.



Incident Information

Please provide information about where the incident occurred.